Patient and Physician Intervention to Increase Organ Donation (DECIDE)

February 19, 2015 updated by: Daryl Thornton, Case Western Reserve University

Patient and Physician Intervention to Increase Organ Donation in Primary Care Settings

The number of persons on the national solid organ waiting list continues to increase while the number of donated organs has failed to keep pace. In some portions of northeastern Ohio the donation rate is as low as 32%. There is a positive association between discussing organ donation with a primary care physician and signing a donor card. However, such discussions are rare. The investigators propose a blinded randomized controlled trial to evaluate the effectiveness of two interventions: 1) showing a donation video to patients in primary care settings waiting to see their physician and 2) cueing of primary care providers to have donation discussions with their patients. The study will be conducted throughout Cuyahoga County in at least 10 ambulatory clinics associated with a single county medical system. Nine hundred patients over 15.5 years of age will be enrolled. The investigators hypothesize that patients exposed to the interventions will be 1) more likely to consent to donate organs, 2) more likely to have donation discussions with their primary care providers, and 3) equally satisfied with the time spent with their doctor compared to patients who are not exposed to the interventions.

Study Overview

Study Type

Interventional

Enrollment (Actual)

916

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44109
        • The MetroHealth System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 78 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • At least 2 visits with their primary care provider in the last 3 years
  • Not previously consented to organ donation
  • At least 15.5 years of age
  • Less than 78 years of age

Exclusion Criteria:

  • Visually impaired
  • Cognitively impaired
  • Non-English speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care
Following enrollment, participants will visit with their primary care provider per usual.
Experimental: Participant Video and Provider Cueing
Participants will watch a video prior to meeting with their provider. Participants will then cue their providers to discuss organ donation with them.
Participants will watch a 5-minute video and then select a question about donation to discuss with their primary care provider (provider cueing).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of participants who consent to donate organs
Time Frame: 1 Day
Consent either on the electronic donor registry or by completion of a organ donor card.
1 Day

Secondary Outcome Measures

Outcome Measure
Time Frame
Proportion of participants who reported holding donation discussions with their primary care provider
Time Frame: 1 Day
1 Day

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of participants who were satisfied with time spent with their provider on the study date
Time Frame: 1 Day
Proportion of participants who were somewhat or very satisfied with the amount of time spent with their provider during the date of the study.
1 Day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John D Thornton, MD, MPH, Case Western Reserve University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

May 1, 2014

Study Registration Dates

First Submitted

September 28, 2012

First Submitted That Met QC Criteria

October 1, 2012

First Posted (Estimate)

October 2, 2012

Study Record Updates

Last Update Posted (Estimate)

February 23, 2015

Last Update Submitted That Met QC Criteria

February 19, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 6 R39OT22056-01-01
  • R39OT22056 (Other Grant/Funding Number: Health Resources and Services Administration)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication

Clinical Trials on Participant Video and Provider Cueing

3
Subscribe